Paul Averback

Chief Executive Officer at NYMOX PHARMACEUTICAL CORPORATION

Net worth: 4 M $ as of 2025-06-29

75 year

76 connections

Health Technology

Consumer Services

Distribution Services

Profile

Paul Averback is the founder of Nymox Pharmaceutical Corp.
since 1995, holding the title of Co-Chairman, President & Chief Executive Officer.
Former job includes President at DMS Pharmaceutical Group, Inc. Education includes a doctorate from the University of Cambridge, conferred in 1975.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NYMOX PHARMACEUTICAL CORP 37.43%	2025-04-18	35,008,010 ( 37.43% )	4 M $	2025-06-29

Paul Averback active positions

Companies	Position	Start
NYMOX PHARMACEUTICAL CORPORATION	Chief Executive Officer	1995-09-29

All active positions of Paul Averback

Former positions of Paul Averback

Companies	Position	End
DMS Pharmaceutical Group, Inc. DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products	President	-

See the detail of Paul Averback's experience

Training of Paul Averback

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Averback's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Nymox Pharmaceutical Corp. Nymox Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which specializes in the research and development of products for the aging population	Health Technology
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
DMS Pharmaceutical Group, Inc. DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products	Distribution Services